Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Eagan

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reports|September 1, 1976
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomasE T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.
Oncology|January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumorsR T Eagan, E T Creagan, H F Bisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data basesE G Shaw, J Q Su, R T Eagan, et al.
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reports|September 1, 1976
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomasE T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology|January 1, 1978
A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasE T Creagan, J H Edmonson, R G Hahn, et al.
Oncology|January 1, 1981
Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumorsR T Eagan, E T Creagan, H F Bisel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data basesE G Shaw, J Q Su, R T Eagan, et al.
Cancer Treatment Reports|May 1, 1978
VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lungR T Eagan, J N Ingle, E T Creagan, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Tumori|February 28, 1979
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lungR T Eagan, E T Creagan, J N Ingle, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanomaD L Ahmann, H F Bisel, J H Edmonson, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Cancer Treatment Reports|May 1, 1976
Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancerD L Ahmann, H F Bisel, R T Eagan, et al.
Pageof 11